Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 21.44 Billion USD | 6.13% |
| 2022 | 20.2 Billion USD | -8.47% |
| 2021 | 22.07 Billion USD | -5.35% |
| 2020 | 23.32 Billion USD | 2.95% |
| 2019 | 22.65 Billion USD | -5.27% |
| 2018 | 23.91 Billion USD | -3.29% |
| 2017 | 24.72 Billion USD | -15.65% |
| 2016 | 29.31 Billion USD | -3.92% |
| 2015 | 30.5 Billion USD | 104.22% |
| 2014 | 14.93 Billion USD | -10.97% |
| 2013 | 16.77 Billion USD | 65.97% |
| 2012 | 10.11 Billion USD | 55.85% |
| 2011 | 6.48 Billion USD | 96.75% |
| 2010 | 3.29 Billion USD | 1086.77% |
| 2009 | 277.82 Million USD | 187.49% |
| 2008 | -317.54 Million USD | 26.77% |
| 2007 | -433.64 Million USD | -2.58% |
| 2006 | -422.72 Million USD | -4972.95% |
| 2005 | -8.33 Million USD | -101.89% |
| 2004 | 441.32 Million USD | -36.01% |
| 2003 | 689.66 Million USD | -0.23% |
| 2002 | 691.27 Million USD | 277.83% |
| 2001 | -388.73 Million USD | -163.35% |
| 2000 | 613.58 Million USD | 1611.29% |
| 1999 | -40.6 Million USD | -183.54% |
| 1998 | 48.6 Million USD | 1529.41% |
| 1997 | -3.4 Million USD | -236.0% |
| 1996 | 2.5 Million USD | 117.73% |
| 1995 | -14.1 Million USD | -265.88% |
| 1994 | 8.5 Million USD | -55.03% |
| 1993 | 18.9 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 20.78 Billion USD | -1.17% |
| 2024 Q2 | 21.03 Billion USD | -1.24% |
| 2024 Q1 | 21.29 Billion USD | -0.67% |
| 2023 Q3 | 21.67 Billion USD | -18.13% |
| 2023 FY | 21.44 Billion USD | 6.13% |
| 2023 Q4 | 21.44 Billion USD | -1.06% |
| 2023 Q2 | 26.46 Billion USD | 31.45% |
| 2023 Q1 | 20.13 Billion USD | -0.33% |
| 2022 Q4 | 20.2 Billion USD | -2.54% |
| 2022 FY | 20.2 Billion USD | -8.47% |
| 2022 Q1 | 21.91 Billion USD | -0.69% |
| 2022 Q2 | 21.15 Billion USD | -3.49% |
| 2022 Q3 | 20.72 Billion USD | -2.01% |
| 2021 Q3 | 21.66 Billion USD | -4.95% |
| 2021 Q1 | 23.05 Billion USD | -1.12% |
| 2021 Q4 | 22.07 Billion USD | 1.86% |
| 2021 Q2 | 22.79 Billion USD | -1.14% |
| 2021 FY | 22.07 Billion USD | -5.35% |
| 2020 Q4 | 23.32 Billion USD | -0.2% |
| 2020 Q3 | 23.36 Billion USD | -0.41% |
| 2020 FY | 23.32 Billion USD | 2.95% |
| 2020 Q1 | 23.51 Billion USD | 3.81% |
| 2020 Q2 | 23.46 Billion USD | -0.23% |
| 2019 Q1 | 23.39 Billion USD | -2.14% |
| 2019 FY | 22.65 Billion USD | -5.27% |
| 2019 Q4 | 22.65 Billion USD | -0.39% |
| 2019 Q3 | 22.74 Billion USD | -1.98% |
| 2019 Q2 | 23.2 Billion USD | -0.85% |
| 2018 Q4 | 23.91 Billion USD | 0.64% |
| 2018 FY | 23.91 Billion USD | -3.29% |
| 2018 Q3 | 23.75 Billion USD | -2.03% |
| 2018 Q2 | 24.25 Billion USD | -0.45% |
| 2018 Q1 | 24.35 Billion USD | -1.48% |
| 2017 Q4 | 24.72 Billion USD | -5.55% |
| 2017 Q3 | 26.17 Billion USD | -3.93% |
| 2017 Q1 | 27.34 Billion USD | -6.72% |
| 2017 FY | 24.72 Billion USD | -15.65% |
| 2017 Q2 | 27.24 Billion USD | -0.34% |
| 2016 Q2 | 30.21 Billion USD | -1.48% |
| 2016 Q1 | 30.66 Billion USD | 0.53% |
| 2016 FY | 29.31 Billion USD | -3.92% |
| 2016 Q3 | 29.78 Billion USD | -1.42% |
| 2016 Q4 | 29.31 Billion USD | -1.6% |
| 2015 Q4 | 30.5 Billion USD | 3.54% |
| 2015 Q2 | 29.92 Billion USD | 23.87% |
| 2015 FY | 30.5 Billion USD | 104.22% |
| 2015 Q1 | 24.15 Billion USD | 61.71% |
| 2015 Q3 | 29.46 Billion USD | -1.54% |
| 2014 FY | 14.93 Billion USD | -10.97% |
| 2014 Q2 | 16.79 Billion USD | -0.1% |
| 2014 Q3 | 15.46 Billion USD | -7.91% |
| 2014 Q4 | 14.93 Billion USD | -3.41% |
| 2014 Q1 | 16.81 Billion USD | 0.19% |
| 2013 Q3 | 16.8 Billion USD | 103.62% |
| 2013 Q4 | 16.77 Billion USD | -0.17% |
| 2013 Q2 | 8.25 Billion USD | -19.1% |
| 2013 Q1 | 10.2 Billion USD | 0.92% |
| 2013 FY | 16.77 Billion USD | 65.97% |
| 2012 FY | 10.11 Billion USD | 55.85% |
| 2012 Q1 | 6.66 Billion USD | 2.75% |
| 2012 Q2 | 7.15 Billion USD | 7.36% |
| 2012 Q3 | 7.37 Billion USD | 3.03% |
| 2012 Q4 | 10.11 Billion USD | 37.13% |
| 2011 FY | 6.48 Billion USD | 96.75% |
| 2011 Q2 | 4.3 Billion USD | -0.16% |
| 2011 Q3 | 4.97 Billion USD | 15.43% |
| 2011 Q4 | 6.48 Billion USD | 30.46% |
| 2011 Q1 | 4.31 Billion USD | 30.86% |
| 2010 Q1 | 292.19 Million USD | 5.17% |
| 2010 FY | 3.29 Billion USD | 1086.77% |
| 2010 Q3 | 2.64 Billion USD | 1161.18% |
| 2010 Q4 | 3.29 Billion USD | 24.75% |
| 2010 Q2 | 209.55 Million USD | -28.28% |
| 2009 Q3 | -49.4 Million USD | 6.64% |
| 2009 Q2 | -52.91 Million USD | 82.22% |
| 2009 Q4 | 277.82 Million USD | 662.32% |
| 2009 FY | 277.82 Million USD | 187.49% |
| 2009 Q1 | -297.69 Million USD | -17.27% |
| 2008 FY | -317.54 Million USD | 26.77% |
| 2008 Q4 | -253.84 Million USD | -15.91% |
| 2008 Q3 | -219 Million USD | 38.14% |
| 2008 Q1 | -431.53 Million USD | 0.49% |
| 2008 Q2 | -354.05 Million USD | 17.95% |
| 2007 Q2 | -469.45 Million USD | -2.45% |
| 2007 FY | -433.64 Million USD | -2.58% |
| 2007 Q3 | -411.9 Million USD | 12.26% |
| 2007 Q1 | -458.23 Million USD | -8.4% |
| 2007 Q4 | -433.64 Million USD | -5.28% |
| 2006 Q2 | -152.93 Million USD | -76.39% |
| 2006 FY | -422.72 Million USD | -4972.95% |
| 2006 Q1 | -86.7 Million USD | -940.45% |
| 2006 Q3 | -205.12 Million USD | -34.13% |
| 2006 Q4 | -422.72 Million USD | -106.08% |
| 2005 Q3 | 120.61 Million USD | -40.57% |
| 2005 Q1 | 380.62 Million USD | -13.75% |
| 2005 Q2 | 202.95 Million USD | -46.68% |
| 2005 Q4 | -8.33 Million USD | -106.91% |
| 2005 FY | -8.33 Million USD | -101.89% |
| 2004 Q4 | 441.32 Million USD | -19.15% |
| 2004 Q2 | 592.28 Million USD | -8.24% |
| 2004 Q1 | 645.45 Million USD | -6.41% |
| 2004 Q3 | 545.86 Million USD | -7.84% |
| 2004 FY | 441.32 Million USD | -36.01% |
| 2003 Q4 | 689.66 Million USD | -8.49% |
| 2003 Q3 | 753.63 Million USD | 1.98% |
| 2003 Q2 | 739.02 Million USD | 23.94% |
| 2003 Q1 | 596.27 Million USD | -13.74% |
| 2003 FY | 689.66 Million USD | -0.23% |
| 2002 Q4 | 691.27 Million USD | 80.26% |
| 2002 Q1 | 7.74 Million USD | 101.99% |
| 2002 Q3 | 383.47 Million USD | -26.27% |
| 2002 Q2 | 520.1 Million USD | 6618.8% |
| 2002 FY | 691.27 Million USD | 277.83% |
| 2001 Q4 | -388.73 Million USD | -203.33% |
| 2001 FY | -388.73 Million USD | -163.35% |
| 2001 Q1 | 563.94 Million USD | -8.09% |
| 2001 Q2 | 502.11 Million USD | -10.96% |
| 2001 Q3 | 376.2 Million USD | -25.08% |
| 2000 Q2 | -146.15 Million USD | 16.17% |
| 2000 FY | 613.58 Million USD | 1611.29% |
| 2000 Q1 | -174.35 Million USD | -329.44% |
| 2000 Q4 | 613.58 Million USD | 1373.26% |
| 2000 Q3 | -48.19 Million USD | 67.03% |
| 1999 Q2 | 40.3 Million USD | -14.62% |
| 1999 Q3 | 103.3 Million USD | 156.33% |
| 1999 Q4 | -40.6 Million USD | -139.3% |
| 1999 FY | -40.6 Million USD | -183.54% |
| 1999 Q1 | 47.2 Million USD | -2.88% |
| 1998 Q1 | 8.1 Million USD | 338.24% |
| 1998 Q3 | 13.4 Million USD | 244.09% |
| 1998 Q2 | -9.3 Million USD | -214.81% |
| 1998 FY | 48.6 Million USD | 1529.41% |
| 1998 Q4 | 48.6 Million USD | 262.69% |
| 1997 Q1 | 3 Million USD | 20.0% |
| 1997 Q4 | -3.4 Million USD | -130.63% |
| 1997 Q3 | 11.1 Million USD | 33.73% |
| 1997 Q2 | 8.3 Million USD | 176.67% |
| 1997 FY | -3.4 Million USD | -236.0% |
| 1996 Q2 | -12.2 Million USD | 33.33% |
| 1996 Q3 | -6.8 Million USD | 44.26% |
| 1996 Q4 | 2.5 Million USD | 136.76% |
| 1996 Q1 | -18.3 Million USD | -29.79% |
| 1996 FY | 2.5 Million USD | 117.73% |
| 1995 Q4 | -14.1 Million USD | -0.49% |
| 1995 FY | -14.1 Million USD | -265.88% |
| 1995 Q3 | -14.03 Million USD | 0.63% |
| 1995 Q1 | 1.6 Million USD | -81.18% |
| 1995 Q2 | -14.12 Million USD | -982.54% |
| 1994 Q4 | 8.5 Million USD | 0.0% |
| 1994 FY | 8.5 Million USD | -55.03% |
| 1993 FY | 18.9 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.65 Billion USD | -706.362% |
| Catalent, Inc. | 4.69 Billion USD | -356.289% |
| Emergent BioSolutions Inc. | 765.8 Million USD | -2699.817% |
| Elanco Animal Health Incorporated | 5.42 Billion USD | -295.444% |
| Perrigo Company plc | 3.32 Billion USD | -545.405% |
| Teva Pharmaceutical Industries Limited | 16.92 Billion USD | -26.667% |
| Zoetis Inc. | 4.76 Billion USD | -350.252% |